INS and gestational diabetes: Multiple hypotheses link aberrant hormone production in the placenta to maternal metabolic dysfunction and diminished insulin functionality [20,32] or GDM development due to the aberrant adaption of the maternal immune system to pregnancy and the increased release of circulating inflammatory factors [33,34].